Anacor Pharma (ANAC) Tops Q1 EPS by 19c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Anacor Pharma (ANAC) Tops Q1 EPS by 19c

Anacor Pharmaceuticals Reports First Quarter 2015 Financial Results

May 6, 2015 4:01 PM EDT

PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced its financial results for the quarter ended March 31, 2015.

We continue to work with our partner Sandoz to optimize the commercial opportunity for KERYDIN® and believe, based on the continued growth in prescriptions, that we are making good progress, said Paul L. Berns, Chairman and Chief Executive Officer of Anacor. In addition, we recently completed enrollment in both of our pivotal Phase 3 studies of AN2728 in patients with mild-to-moderate atopic dermatitis and continue to expect to announce top-line data in the third... More